Patent Application
20220008626
The present disclosure generally relates to hydration solutions for hydrating or wetting a device. More particularly, the present disclosure generally relates to liquid hydration solutions that contain volatile solutes and assemblies that contain the same. The present disclosure also generally relates to medical device products that contain such hydration solutions, and methods of making such solutions and medical device products.
Several different devices in different industries are required to be hydrated prior to use and/or stored in a hydrated condition. In several instances, such devices are stored or packaged in a hydration medium, such as a liquid hydration medium. Liquid hydration mediums may be, but are not limited to, water or aqueous solutions.
One type of device wherein it may be advantageous to package the device in a hydrated stated and/or in a hydration medium is a medical device that is made from a hydrophilic material, such as a hydrophilically coated urinary catheter. In several applications, a coating of hydrophilic material is applied to the surface of a device to provide a lubricious surface. When the hydrophilic material is wetted or hydrated with a hydration medium, the hydrophilic material becomes extremely lubricous. The hydration medium may be, for example, liquid water or an aqueous solution. In the field of insertable medical devices, the lubriciousness of the hydrophilic coating can ease introduction of the device into the body and aids in reducing pain and discomfort associated with such introduction.
In devices that are required to be stored in and/or hydrated with a hydration medium, the device may be packaged with the hydration medium, such that the device is in contact with the hydration medium. In such packaged products, the hydration medium hydrates the device.
In the field of intermittent hydrophilic urinary catheters, the package may contain the urinary catheter and hydration liquid wherein the liquid is in contact with and hydrates the hydrophilic material of the catheter. Such catheters are used for self-catheterization about five to six times a day. Thus, the user may carry a supply of catheters with them. If the user is in a colder climate, the packaged catheters may be exposed to cold temperatures. Exposure to colder temperatures may cause the water within the package and within hydrophilic coating to freeze. Such freezing of the water may degrade or cause issues with the hydrophilic material of the catheter.
Therefore, there remains a need for improved hydration mediums for packaged medical device products and methods of hydrating devices within a package and/or packaging a device with a hydration medium.
There are several aspects of the present subject matter which may be embodied separately or together in the devices and systems described and claimed below. These aspects may be employed alone or in combination with other aspects of the subject matter described herein, and the description of these aspects together is not intended to preclude the use of these aspects separately or the claiming of such aspects separately or in different combinations as set forth in the claims appended hereto.
In one aspect, a hydration medium for hydrating or wetting a device. The hydration medium comprising a solution including a liquid and a volatile solute dissolved in the liquid.
In another aspect, a packaged device including a package containing the device and a hydration medium comprising a solution including a liquid and a volatile solute dissolved in the liquid.
In yet another aspect, a method of making a urinary catheter product. The method includes placing a hydrophilic catheter within a package. A first component and a second component are dispensed into the package. The first component and the second component are combined to produce a hydration solution including a liquid and a volatile solute dissolved in the liquid, wherein the hydration solution wets hydrates a hydrophilic material of the hydrophilic catheter.
The embodiments disclosed herein are for the purpose of providing a description of the present subject matter, and it is understood that the subject matter may be embodied in various other forms and combinations not shown in detail. Therefore, specific embodiments and features disclosed herein are not to be interpreted as limiting the subject matter as defined in the accompanying claims.
The present disclosure is directed to a hydration medium that is a liquid hydration solution which may be used to hydrate or wet a device or product. The liquid hydration solution may be placed in a package with a device or product wherein the hydration solution directly contacts the device or product to hydrate or wet the device.
The hydration solution includes a solvent, which is a hydration liquid that hydrates the product, and a dissolved volatile solute dissolved in the hydration liquid. Volatile solutes also may impart sensory benefits (e.g. fragrance), as well and functional benefits (preservative and freeze thaw protection). The liquid may be water or any other suitable hydration liquid, and the volatile solute may be one or more gases dissolved in the liquid to form the hydration solution. In one embodiment, the hydration solution may be saturated or supersaturated with gas. The gas or other volatile solute may include one or more of carbon dioxide, nitrogen, and/or sulfur dioxide. When sulfur dioxide gas is dissolved in the hydration solution, the sulfur dioxide gas may serve as, and/or give rise to or produce non-volatile preservatives, such as sulfites.
In one alternative, the addition of sulfur dioxide to the hydration liquid (not containing sulfite salts) will result in a reduction of pH of the solution, which will provide a preservative effect. In this alternative, little or no sulfite is formed, and the sulfur dioxide gas remains as a hydrated gas and a volatile preservative.
When addition of sulfur dioxide leads to the formation of a non-volatile preservative, such preservatives may include sulfites. Such sulfites may include, for example, sodium sulphite, sodium bisulfite, sodium hydrogen sulphite, sodium metabisulfite, potassium metabisulfite, calcium sulphite, calcium bisulfite, calcium hydrogen sulphite, or potassium bisulfite. The formation and identity of the preservative formed in the solution may depend on other materials present in the formulation. For example, volatile sulfur dioxide gas and a salt may be included in the hydration liquid to generate non-volatile sulfite preservatives in the hydration liquid. Such salts may include, but are not limited to, sodium sulfite, sodium bisulfite, sodium hydrogen sulphite, sodium metabisulfite, potassium metabisulfite, calcium sulfite, calcium bisulfite, calcium hydrogen sulfite, or potassium bisulfite.
The preservative may, for example, prevent decomposition of the hydrophilic coating, prevent microbial growth, maintain pH or otherwise stabilize the chemical environment within the catheter package.
The volatile solute or agent may also include a volatile oil, such as hydrocarbon volatile oils, alcoholic volatile oils, aldehyde volatile oils, phenolic volatile oils, ketonic volatile oils, phenolic ether volatile oils, oxidized volatile oils, etc. The concentration levels of the dissolved gas within the hydration liquid may be any suitable level and at times may be higher than saturation equilibrium.
As will be explained in more detail below, the hydration solution and a medical device may be packaged in a sealed gas impermeable package. The hydration solution will be under pressure within the package so that the gas remains dissolved within the hydration solution while the package is sealed. While the gas is dissolved within the hydration solution, the gas suppresses the freezing point of the hydration liquid, such that the freezing point of the hydration solution is less than that of the hydration liquid.
The gas may be dissolved in the liquid by any suitable method. For example, gas may be dosed into the package at high pressures and the package may then be sealed. Under the high pressure within the package, the gas dissolves in the liquid to form the hydration solution. In another example, reactants may be placed in the package with the liquid and the package is sealed. When the reactants react, they produce gas within the package. The reactants may be any reactants that produce a gas. For example, the reactants may be sodium bicarbonate and citric acid. The reactants may be in two separate liquids that are mixed within the package. In one embodiment, a packaging containing a medical device may receive a first liquid of water and sodium bicarbonate and a second liquid of water and citric acid. The package may then be sealed. In another embodiment, one or both of the reactants may be dispensed into the package in solid form, along with a liquid. The liquid may dissolve the solid reactants and the reactants react to form the gas. The gas increases the pressure within the package such that a portion of the gas dissolves within the liquid to form the hydration solution. When the package is opened by the user and the hydration liquid is exposed to atmospheric pressure, the gas leaves the liquid or effervesces.
The hydration solution may include other components as well, such as viscosity increasing agents, stain reducing agents, osmolality increasing agents, etc. The viscosity increasing agents, may include but are not limited to, glycerol, polyethylene glycol, sugar alcohols, polyols, sugars, soluble polymers including polysaccharides, polyvinylpyrrolidone, polyethylene oxide, cationic or anionic polyelectrolytes including polyampholytes. The hydration solution may further include a salt, such as sodium chloride. The hydration solution may comprise a polymer, such as a hydrophilic polymer. The hydrophilic polymer may be a synthetic or natural hydrophilic polymer. In one embodiment, the polymer may include polyvinylpyrrolidone. In another embodiment, the polymer may include a polysaccharide.
Turning now to
The package 10 may be any suitable package for holding the device. In the illustrated embodiment, the package 10 includes a front sheet 14 and a back sheet 15 (
The front sheet 14 and back sheet 15 may be made from a liquid and gas impermeable material. For example, the front and back sheets 14 and 15 may be made from a polymer film and/or a metal film. In one embodiment, the material may be a polymer/metal laminate, such as a polymer/aluminum laminate.
The front sheet 14 and back sheet 15 may be sealed to each other to define a cavity for holding the catheter 12. The front sheet 14 and back sheet 15 may be sealed to each other to form a gas tight cavity. In the illustrated embodiment, the front sheet 14 and back sheet 15 are sealed to each other by a peripheral seal 26. The peripheral seal 26 may be a peelable seal that may be a heat seal, an adhesive seal or any other suitable peelable seal that allows the front sheet 14 to be separated from the back sheet 15 when the sheets are peeled apart during use.
Referring back to
For example, referring to
In another embodiment, the first spout 34 may dispense a hydration liquid and the second spout 38 and/or a third spout may dispense solid forms of the reactants. In yet another embodiment, the first spout 34 may dispense a hydration liquid containing a first reactant and the second spout 38 may dispense the second reactant in a solid form. In yet a further embodiment, the first spout 34 may dispense a hydration liquid into the package and the second spout 38 may dispense gas at a high pressure.
Referring to
It will be understood that the embodiments described above are illustrative of some of the applications of the principles of the present subject matter. Numerous modifications may be made by those skilled in the art without departing from the spirit and scope of the claimed subject matter, including those combinations of features that are individually disclosed or claimed herein. For these reasons, the scope hereof is not limited to the above description but is as set forth in the following claims, and it is understood that claims may be directed to the features hereof, including as combinations of features that are individually disclosed or claimed herein.
The present application claims the benefit and priority of U.S. Provisional Patent Application No. 62/770,294, filed Nov. 21, 2018, which is hereby incorporated herein by reference.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US2019/062365 | 11/20/2019 | WO | 00 |
| Number | Date | Country | |
|---|---|---|---|
| 62770294 | Nov 2018 | US |
